Remedium Bio is a Boston based gene therapy company focused on the development of highly innovative treatments for a broad range of diseases. The Remedium approach utilizes proven scientific fundamentals, in a novel way, to treat the most debilitating conditions. Our leading candidates include a gene therapy treatment for Osteoarthritis, delivered via an intrinsically safe Adeno-Associated Viral (AAV) vector, a treatment to alleviate hyperglycemia in Type 1 and Type 2 Diabetes, and a gene therapy product to improve long term survival post Myocardial Infarction.
The Remedium Bio pipeline consists of a broad range of therapies for immune and age related conditions. The treatment modalities are founded in proven scientific fundamentals and focused on therapeutic treatments using a novel approach.
There is so much to life
The only worthy purpose is saving it!
Remedium therapies are based on proven fundamental components including clinically validated targets, commercial delivery vectors, and time-tested manufacturing technologies.
The technology is then applied to treating disease using a fundamentally novel, patent pending approach. An approach, uniquely matched specifically with the target condition.
Each technology serves as a potential platform, from treating conditions resulting from age related decline, to replacing extracellular proteins in a safe and adjustable way.
Get In Touch
We are always interested in starting a new conversation and are looking forward to hearing from you. Thank you in advance for your inquiry and please have a wonderful day!
1116 Great Plain Ave, Suite 203
P: +1 (978) 467 5217